US FDA ‘Brainstorms’ For Ways To Resume Pre-Pandemic Inspection Cadence
Executive Summary
The FDA's drug inspections director discusses trends and challenges in remarks at a Georgia GMP conference, while declining to share specific ideas generated in last week’s agency brainstorming session.
You may also be interested in...
US FDA Pharmaceutical Quality Operations Chief Outlines Paths To Quicker Inspections
As US pharmaceutical inspectorate advances toward pre-pandemic inspection cadence, there's new focus on accelerating site inspection process, as well as effort to improve retention with quicker, more targeted training. OPQO chief Alonza Cruse reviews key ideas at GMP conference.
US FDA's Cruse Outlines Paths To Quicker Inspections
As US pharmaceutical inspectorate advances toward its pre-pandemic inspection cadence, there is a new focus on accelerating the site inspection process, as well as an effort to improve retention with quicker, more targeted training. OPQO chief Alonza Cruse reviews key ideas at GMP conference.
Congress Explores Plans For Catching Up On US FDA Foreign Inspections
Absent agency said to have a plan to overcome vacancies and clear inspection backlog; subcommittee has other plans.